Division of Cancer Treatment and Diagnosis
E16765
The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Division of Cancer Treatment and Diagnosis canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T129527 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Division of Cancer Treatment and Diagnosis Context triple: [National Cancer Institute, hasDivision, Division of Cancer Treatment and Diagnosis]
-
A.
Division of Cancer Biology
The Division of Cancer Biology is a branch of the National Cancer Institute that supports and coordinates research on the fundamental biological mechanisms underlying cancer development and progression.
-
B.
Division of Cancer Prevention
The Division of Cancer Prevention is a branch of the National Cancer Institute that leads research and programs focused on preventing cancer, detecting it early, and reducing cancer risk.
-
C.
Division of Cancer Control and Population Sciences
The Division of Cancer Control and Population Sciences is a branch of the National Cancer Institute that leads research and programs focused on understanding cancer burden, risk factors, prevention, and outcomes at the population level.
-
D.
Division of Cancer Epidemiology and Genetics
The Division of Cancer Epidemiology and Genetics is a research branch of the U.S. National Cancer Institute that investigates the causes, distribution, and genetic factors of cancer in human populations.
-
E.
NCI-Designated Cancer Centers Program
The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Division of Cancer Treatment and Diagnosis Target entity description: The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
-
A.
Division of Cancer Biology
The Division of Cancer Biology is a branch of the National Cancer Institute that supports and coordinates research on the fundamental biological mechanisms underlying cancer development and progression.
-
B.
Division of Cancer Prevention
The Division of Cancer Prevention is a branch of the National Cancer Institute that leads research and programs focused on preventing cancer, detecting it early, and reducing cancer risk.
-
C.
Division of Cancer Control and Population Sciences
The Division of Cancer Control and Population Sciences is a branch of the National Cancer Institute that leads research and programs focused on understanding cancer burden, risk factors, prevention, and outcomes at the population level.
-
D.
Division of Cancer Epidemiology and Genetics
The Division of Cancer Epidemiology and Genetics is a research branch of the U.S. National Cancer Institute that investigates the causes, distribution, and genetic factors of cancer in human populations.
-
E.
NCI-Designated Cancer Centers Program
The NCI-Designated Cancer Centers Program is a U.S. network of leading academic and research institutions recognized for excellence in cancer research, treatment, and prevention.
- F. None of above. chosen
Statements (45)
| Predicate | Object |
|---|---|
| instanceOf |
division of a government agency
ⓘ
research organization unit ⓘ |
| affiliation |
United States Department of Health and Human Services
ⓘ
surface form:
U.S. Department of Health and Human Services
|
| country |
United States of America
ⓘ
surface form:
United States
|
| field |
cancer research
ⓘ
clinical oncology ⓘ drug development ⓘ medical diagnostics ⓘ oncology ⓘ translational research ⓘ |
| focus |
biomarker development
ⓘ
cancer diagnosis ⓘ cancer treatment ⓘ clinical trials ⓘ combination cancer therapies ⓘ early-phase clinical trials ⓘ imaging technologies for cancer ⓘ precision oncology ⓘ therapeutic development ⓘ translational clinical research ⓘ |
| goal |
to accelerate translation of laboratory discoveries into clinical applications
ⓘ
to expand access to innovative cancer treatments through clinical trials ⓘ to facilitate regulatory approval of effective cancer therapies ⓘ to improve outcomes for cancer patients ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
federal government of the United States
|
| locatedIn | Bethesda, Maryland ⓘ |
| mission |
to support the clinical testing of new cancer diagnostic tools
ⓘ
to support the clinical testing of new cancer therapies ⓘ to support the development of new cancer diagnostic tools ⓘ to support the development of new cancer therapies ⓘ to support the evaluation of new cancer diagnostic tools ⓘ to support the evaluation of new cancer treatments ⓘ |
| operatedBy | National Cancer Institute ⓘ |
| parentOrganization |
National Cancer Institute
ⓘ
National Institutes of Health ⓘ |
| partOf | National Cancer Institute ⓘ |
| sector | public sector ⓘ |
| supports |
clinical trial networks
ⓘ
cooperative research groups ⓘ development of anticancer drugs ⓘ development of biologic cancer therapies ⓘ development of cancer diagnostic assays ⓘ development of cancer imaging agents ⓘ investigator-initiated clinical trials ⓘ |
| website | https://dctd.cancer.gov/ ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Division of Cancer Treatment and Diagnosis Description of subject: The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.